Strategic Partnership: Torrent Pharma & Zydus Collaborate On Liver Disease Drug
Under the terms of the agreement, Torrent Pharmaceuticals secures semi-exclusive rights to co-market the product in India, branding it as Vorxar, according to a statement released by Torrent. Zydus Lifesciences, the original developer, had initially launched the drug under the brand names Lipaglyn and Bilypsa and will continue to market them.